A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass
- PMID: 23161525
- PMCID: PMC4641311
- DOI: 10.1007/s11695-012-0802-1
A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass
Abstract
Background: Gastric bypass has profound effects on glycemic control in adults with type 2 diabetes mellitus. The goal of this study was to examine the long-term rates and clinical predictors of diabetes remission and relapse among patients undergoing gastric bypass.
Methods: We conducted a retrospective cohort study of adults with uncontrolled or medication-controlled type 2 diabetes who underwent gastric bypass from 1995 to 2008 in three integrated health care delivery systems in the USA. Remission and relapse events were defined by diabetes medication use and clinical laboratory measures of glycemic control. We identified 4,434 adults with uncontrolled or medication-controlled type 2 diabetes who had gastric bypass.
Results: Overall, 68.2 % (95 % confidence interval [CI], 66 and 70 %) experienced an initial complete diabetes remission within 5 years after surgery. Among these, 35.1 % (95 % CI, 32 and 38 %) redeveloped diabetes within 5 years. The median duration of remission was 8.3 years. Significant predictors of complete remission and relapse were poor preoperative glycemic control, insulin use, and longer diabetes duration. Weight trajectories after surgery were significantly different for never remitters, relapsers, and durable remitters (p = 0.03).
Conclusions: Gastric bypass surgery is associated with durable remission of type 2 diabetes in many but not all severely obese diabetic adults, and about one third experience a relapse within 5 years of initial remission. More research is needed to understand the mechanisms of diabetes relapse, the optimal timing of surgery in effecting a durable remission, and the relationship between remission duration and incident microvascular and macrovascular events.
Figures
Comment in
-
Letter to the editor: a multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.Obes Surg. 2013 Sep;23(9):1454-5. doi: 10.1007/s11695-013-0959-2. Obes Surg. 2013. PMID: 23636991 No abstract available.
-
The authors respond: a multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass.Obes Surg. 2013 Sep;23(9):1456-7. doi: 10.1007/s11695-013-0960-9. Obes Surg. 2013. PMID: 23636992 No abstract available.
Similar articles
-
Predictors of Long-Term Remission and Relapse of Type 2 Diabetes Mellitus Following Gastric Bypass in Severely Obese Patients.Obes Surg. 2018 Jan;28(1):195-203. doi: 10.1007/s11695-017-2830-3. Obes Surg. 2018. PMID: 28770424
-
Preoperative Prediction of Type 2 Diabetes Remission After Gastric Bypass Surgery: a Comparison of DiaRem Scores and ABCD Scores.Obes Surg. 2016 Oct;26(10):2418-24. doi: 10.1007/s11695-016-2120-5. Obes Surg. 2016. PMID: 26932813
-
Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes.Ann Surg. 2010 Dec;252(6):966-71. doi: 10.1097/SLA.0b013e3181efc49a. Ann Surg. 2010. PMID: 21107106
-
Potential of surgery for curing type 2 diabetes mellitus.Ann Surg. 2002 Nov;236(5):554-9. doi: 10.1097/00000658-200211000-00003. Ann Surg. 2002. PMID: 12409659 Free PMC article. Review.
-
Gastrointestinal metabolic surgery for the treatment of type 2 diabetes mellitus.World J Gastroenterol. 2014 Oct 21;20(39):14315-28. doi: 10.3748/wjg.v20.i39.14315. World J Gastroenterol. 2014. PMID: 25339819 Free PMC article. Review.
Cited by
-
Is There a Correlation Between Preoperative HbA1c Change, Long-Term Weight Loss and Glycaemic Control in Patients With Type 2 Diabetes Undergoing Metabolic Surgery?Cureus. 2024 Oct 6;16(10):e70921. doi: 10.7759/cureus.70921. eCollection 2024 Oct. Cureus. 2024. PMID: 39502975 Free PMC article.
-
Human Gut Microbiome Before and After Bariatric Surgery in Obese Patients with and Without Type 2 Diabetes.Obes Surg. 2024 Aug;34(8):2835-2843. doi: 10.1007/s11695-024-07364-5. Epub 2024 Jun 24. Obes Surg. 2024. PMID: 38913272
-
Phenotype execution and modeling architecture to support disease surveillance and real-world evidence studies: English sentinel network evaluation.JAMIA Open. 2024 May 10;7(2):ooae034. doi: 10.1093/jamiaopen/ooae034. eCollection 2024 Jul. JAMIA Open. 2024. PMID: 38737141 Free PMC article.
-
Effect of bariatric surgery on metabolism in diabetes and obesity comorbidity: Insight from recent research.World J Diabetes. 2024 Apr 15;15(4):586-590. doi: 10.4239/wjd.v15.i4.586. World J Diabetes. 2024. PMID: 38680688 Free PMC article.
-
Diabetic Markers, Five Years after Bariatric Surgery.Middle East J Dig Dis. 2023 Oct;15(4):270-276. doi: 10.34172/mejdd.2023.357. Epub 2023 Oct 30. Middle East J Dig Dis. 2023. PMID: 38523888 Free PMC article.
References
-
- Pories WJ, Dohm LG, Mansfield CJ. Beyond the BMI: the search for better guidelines for bariatric surgery. Obesity (Silver Spring) 2010;18:865–71. - PubMed
-
- Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248–56. e5. - PubMed
-
- Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724–37. - PubMed
-
- Pories WJ, MacDonald KG, Jr., Morgan EJ, et al. Surgical treatment of obesity and its effect on diabetes: 10-y follow-up. Am J Clin Nutr. 1992;55:582S–5S. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
